Skip to content

Research and Application of a Novel Micro-Invasive, Fully Digital Workflow Surgical Robot for Edentulous Jaw Implantology

Research and Application of a Novel Micro-Invasive, Fully Digital Workflow Surgical Robot for Edentulous Jaw Implantology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114969
Enrollment
Unknown
Registered
2025-12-19
Start date
2025-10-25
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Edentulous jaw

Interventions

Edentulous Jaw Robotics Group:None

Sponsors

West China Hospital of Stomatology, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients voluntarily participate in the clinical trial and sign an informed consent form; 2.Aged 18–70 years (inclusive), of any gender; 3.Suffering from complete tooth loss requiring full-arch implant restoration and meeting the indications for dental implant surgery; 4.Good compliance, willing and able to attend follow-up visits as required; 5.Edentulous space, jaw relationship, and other relevant factors meet prosthetic requirements.

Exclusion criteria

Exclusion criteria: 1.Individuals who have participated in other medical technology trials within the past 3 months; 2.Patients allergic to any material used in the product; 3.Patients with uncontrolled endocrine or metabolic disorders, hematological diseases, or cardiovascular diseases; 4.Systemic or local bone disorders; 5.Individuals with systemic autoimmune diseases; 6.Neurological disorders, such as epilepsy; 7.Psychiatric disorders or psychological impairments; 8.Pathological mucosal lesions; 9.Post-radiotherapy to the head or neck; 10.Uncontrolled periodontal disease or extremely poor oral hygiene; 11.Parafunctional habits such as bruxism; 12. Insufficient bone volume and/or poor bone quality; 13.Maxillary or mandibular hypoplasia or pathological changes; 14.Xerostomia; 15.Pregnant or lactating women; 16.Long-term use of special medications such as hormones or anticoagulants; 17.Patients with alcohol or drug addiction; 18.Any other conditions that the investigator considers unsuitable for the trial;

Design outcomes

Secondary

MeasureTime frame
Implant Success Rate;

Primary

MeasureTime frame
Implant Placement Accuracy ;Implant Success Rate;

Countries

China

Contacts

Public ContactYang Xingmei

West China Hospital of Stomatology, Sichuan University

65167950@qq.com+86 28 8550 3579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026